Karo Pharma set to acquire Weifa in Nordic deal

24 August 2017 - Deborah Wilkes

Archived

Sweden's Karo Pharma is set to acquire Norwegian consumer healthcare company Weifa – including its Paracet and Ibux pain relievers – in a deal worth NOK1.28 billion (USD0.16 billion).

Click tags below for more information on topics:

Karo Pharma

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: